N-BX200

N-BX200 is an engineered recombinant protein biologic being developed by Neurocarrus. It is designed for indications typically addressed by botulinum toxin (Botox), which include a wide range of aesthetic and therapeutic applications such as the treatment of glabellar lines, muscle spasticity, hyperhidrosis, and chronic migraine. As a recombinant protein, N-BX200 is part of a new generation of neurotoxin-based therapies engineered to potentially offer improved purity, stability, or modified pharmacokinetics compared to traditional tissue-derived botulinum toxin products. The asset is currently in early-stage development as part of Neurocarrus's pipeline of targeted biologics for neuromuscular and aesthetic medicine.